glp-1 digital health startups What's next for innovation: A primer on the race reshaping pharma and chronic disease care Digital health companies are launching

The American Heart Association estimates that one in four adults has high LDL cholesterol

Freebies for Researchers Who Go Big Orders over $75: Receive a FREE Vial Vault, our sleek, secure container to store your research vials

Even without coverage, phentermine remains accessible to most budgets

Further competition comes from tirzepatide, approved by the FDA in 2022 and now sold under the Mounjaro/Zepbound brand name

GLP-1 Medications with a simple generic name of "semaglutide", "liraglutide", "tirzepatide", "dulaglutide", "exenatide", "exenatide microspheres", or "insulin degludec/liraglutide" and at least one of: A pharmaceutical class of "ANTI-OBESITY GLUCAGON-LIKE PEPTIDE-1 RECEP AGONIST" or "ANTIHYPERGLYCEMIC - INCRETIN MIMETICS COMBINATION" A pharmaceutical class that contains "GLP-1" A pharmaceutical subclass that contains the text "GLP-1"